NCT06387654Recruiting
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Physiopathological Investigations of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 28 Mar 2024
- Start date
- May 2024
- Primary completion date
- Apr 2029
- Lead sponsor
- University Hospital, Toulouse
- NCT number
- NCT06387654
What you commit to
- Study type: Observational
- Planned participants: 800
- From May 2024 to the primary completion date, Apr 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 6 years old
Other
- Patients under protective supervision (guardianship, curators)
- Pregnant or breastfeeding woman
Who the study is looking for
- Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin.
- The patients included may be adults or children, and will be:
- Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),
- Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),
- Patients with cutaneous lupus
- Patients with dysimmune skin diseases (psoriasis, eczema)
- Patients with immuno-induced dermatological disorders or drug dermatitis
- Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.).
- Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected
Age in the registry: 6 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.